UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical commentary on “Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab”

Multiple sclerosis, 2018-03, Vol.24 (3), p.360-362

Salmen, Anke

2018

Volltextzugriff (PDF)

Simultaneous lesion and brain segmentation in multiple sclerosis using deep neural networks

Scientific reports, 2021-01, Vol.11 (1), p.1087-1087, Article 1087

2021

Volltextzugriff (PDF)

Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients

Multiple sclerosis, 2023-01, Vol.29 (1), p.63-73

2023

Volltextzugriff (PDF)

Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis

Journal of neurology, 2021-01, Vol.268 (1), p.276-284

2021

Volltextzugriff (PDF)

Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids

Acta neuropathologica communications, 2024-10, Vol.12 (1), p.160-23, Article 160

2024

Volltextzugriff (PDF)

Waning Humoral Immune Response to SARS-CoV-2 Vaccination with Symptomatic Infection after Initiation of Anti-CD20 Treatment in a Patient with Multiple Sclerosis

Clinical and translational neuroscience, 2022-03, Vol.6 (1), p.8

2022

Volltextzugriff (PDF)

Retinal layer segmentation in a cohort of healthy children via optical coherence tomography

PloS one, 2022-11, Vol.17 (11), p.e0276958-e0276958

2022

Volltextzugriff (PDF)

Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidence

NeuroImage clinical, 2020-01, Vol.25, p.102104-102104, Article 102104

2020

Volltextzugriff (PDF)

Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211030664-17562864211030664

2021

Volltextzugriff (PDF)

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age

Therapeutic advances in neurological disorders, 2019-05, Vol.12, p.1756286419843450-1756286419843450

2019

Volltextzugriff (PDF)

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course

Therapeutic advances in neurological disorders, 2019, Vol.12, p.1756286419878340-1756286419878340

2019

Volltextzugriff (PDF)

Impfstrategien bei Menschen mit MS

InFo Neurologie + Psychiatrie, 2024-01, Vol.26 (1), p.16-17

2024

Volltextzugriff (PDF)

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

EBioMedicine, 2020-06, Vol.56, p.102807-102807, Article 102807

2020

Volltextzugriff (PDF)

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System

Therapeutic advances in neurological disorders, 2022, Vol.15, p.17562864221129383-17562864221129383

2022

Volltextzugriff (PDF)

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211016641-17562864211016641

2021

Volltextzugriff (PDF)

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data

Frontiers in pharmacology, 2023-06, Vol.14, p.1186404-1186404

2023

Volltextzugriff (PDF)

How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis

Multiple sclerosis, 2020-04, Vol.26 (4), p.489-500

2020

Volltextzugriff (PDF)

Pneumococcal serotype determines growth and capsule size in human cerebrospinal fluid

BMC microbiology, 2020-01, Vol.20 (1), p.16-16, Article 16

2020

Volltextzugriff (PDF)

COVID-19 in a Neuroimmunological Outpatient Cohort: The Bernese Experience

Clinical and translational neuroscience, 2022-03, Vol.6 (1), p.6

2022

Volltextzugriff (PDF)

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19

Journal of central nervous system disease, 2022-05, Vol.14, p.11795735221102727-11795735221102727

2022

Volltextzugriff (PDF)

Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis

Scientific reports, 2022-10, Vol.12 (1), p.17829-17829, Article 17829

2022

Volltextzugriff (PDF)

An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211020074-17562864211020074

2021

Volltextzugriff (PDF)

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort

Therapeutic advances in neurological disorders, 2023-01, Vol.16, p.17562864231197309-17562864231197309

2023

Volltextzugriff (PDF)

No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset

Brain and behavior, 2022-06, Vol.12 (6), p.e2592-n/a

2022

Volltextzugriff (PDF)

Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241237853-17562864241237853

2024

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Clinical commentary on “Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab”

Simultaneous lesion and brain segmentation in multiple sclerosis using deep neural networks

Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients

Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis

Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids

Waning Humoral Immune Response to SARS-CoV-2 Vaccination with Symptomatic Infection after Initiation of Anti-CD20 Treatment in a Patient with Multiple Sclerosis

Retinal layer segmentation in a cohort of healthy children via optical coherence tomography

Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidence

Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course

Impfstrategien bei Menschen mit MS

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data

How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis

Pneumococcal serotype determines growth and capsule size in human cerebrospinal fluid

COVID-19 in a Neuroimmunological Outpatient Cohort: The Bernese Experience

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19

Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis

An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort

No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset

Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events

Suchergebnisse filtern